Insulin Resistance and Arterial Stiffness Risk After Menopause

Insulin Resistance and Arterial Stiffness: Why Menopause May Widen the Risk

A study of 306 Chinese women found that one measure of insulin resistance — METS-IR — remained linked to stiffer arteries even after adjusting for age, blood pressure, and kidney function, and the association appeared only in postmenopausal women. The simpler triglyceride-glucose (TyG) index lost its significance under the same adjustments. Published in Frontiers in Endocrinology by researchers at Shandong University of Traditional Chinese Medicine and Guang’anmen Hospital Jinan, the findings add to growing evidence that metabolism shifts after menopause in ways that matter for cardiovascular health.

What the Study Found: METS-IR Beat TyG After Adjustment

Researchers led by Yang and Wang measured brachial-ankle pulse wave velocity (baPWV), a non-invasive marker of how stiff the large arteries have become. Stiffer arteries predict future cardiovascular events independently of blood pressure alone.

They compared two insulin resistance surrogates that don’t require fasting insulin tests. The TyG index uses just fasting triglycerides and glucose. METS-IR is more elaborate, combining fasting glucose, triglycerides, HDL cholesterol, and BMI into a single score.

Both markers correlated with baPWV before adjustment. After accounting for menopausal status, age, systolic blood pressure, uric acid, LDL cholesterol, and kidney function, METS-IR stayed significant (β = 4.72, 95% CI 1.03–8.41, P = 0.012) while TyG did not (β = 26.66, 95% CI −11.49–64.81, P = 0.170). In subgroup analysis, METS-IR tracked arterial stiffness in the 172 postmenopausal women (β = 5.68, P = 0.025) but not the 134 premenopausal women (P = 0.128). Importantly, the interaction term was not significant — meaning this subgroup split could reflect chance rather than a true menopause effect. Cross-sectional design also means causality can’t be inferred.

Why Insulin Resistance Worsens After Menopause

The estrogen decline of menopause does more than end menstruation. Estradiol normally supports insulin sensitivity by improving glucose uptake in muscle, modulating fat distribution, and reducing inflammatory signaling. When ovarian estrogen falls, insulin sensitivity typically drops by 10–20%, visceral fat accumulates, and muscle mass declines — a combination that raises both fasting glucose and triglycerides.

Chronic hyperinsulinemia then damages blood vessels directly. Insulin resistance reduces nitric oxide availability in the endothelium, promotes arterial wall thickening via smooth muscle proliferation, and accelerates glycation of structural proteins in the arterial wall. This may explain why the METS-IR–stiffness link surfaced in postmenopausal women: years of compounded metabolic stress, plus age-related vascular aging. Related research shows early menopause is associated with sarcopenia and muscle loss in a 4,244-woman study, and muscle loss itself worsens glucose disposal — reinforcing the metabolic-vascular loop.

Vitamin D adds another layer. A separate comparative study by Ardelean and colleagues from Romanian institutions (published in Biomedicines) examined vitamin D status and metabolic syndrome across menopausal types, finding that women with early menopause faced distinct metabolic risks — a relevant point since low vitamin D is itself associated with insulin resistance.

What This Means for Women in Perimenopause and Beyond

For clinicians and women tracking metabolic health, the study suggests composite markers like METS-IR may capture cardiometabolic risk better than single fasting measures like TyG, at least in research settings. Both models discriminated elevated arterial stiffness equally well (AUC 0.831 vs 0.834), so in practice, available lab values matter more than the specific formula.

The bigger takeaway is timing. Perimenopause is when insulin resistance begins to climb, often 5–10 years before fasting glucose crosses diagnostic thresholds. Catching the trend early — rising triglycerides, shrinking HDL, creeping waist circumference — allows intervention while arteries are still responsive.

Practical Applications: What You Can Actually Do

• Ask for the full metabolic panel — fasting glucose, triglycerides, HDL, and LDL — not just glucose, since composite markers performed better in this study.
• Prioritize resistance training. Muscle is the body’s main glucose sink; preserving it supports both insulin sensitivity and bone health, as covered in our article on how muscle mass drives bone density after menopause.
• Discuss hormone therapy timing and route with your clinician. Transdermal estrogen is now a preferred route and may influence cardiometabolic risk; see our guide on why estrogen delivery method changes cardiovascular risk.
• Check vitamin D status, particularly with early or surgical menopause, given links to metabolic syndrome.
• Consider omega-3s, magnesium, and adequate protein as evidence-supported supports for triglyceride and glucose metabolism.

Frequently Asked Questions

Does menopause cause insulin resistance directly?

The estrogen decline of menopause reduces insulin sensitivity, but aging, muscle loss, and fat redistribution contribute too. Studies consistently show insulin sensitivity drops around 10–20% across the menopausal transition.

What is the TyG index and can I calculate it?

It’s a simple surrogate for insulin resistance computed from fasting triglycerides and glucose. Your doctor can calculate it from standard blood work, though this study suggests composite scores may perform better for vascular risk.

Should postmenopausal women be screened for arterial stiffness?

BaPWV testing isn’t routine, but women with elevated insulin resistance markers, high blood pressure, or early menopause may benefit from discussing cardiovascular screening with their physician.

Can lifestyle changes reverse insulin resistance after menopause?

Yes. Resistance exercise, adequate protein, weight management, and possibly vitamin D repletion can meaningfully improve insulin sensitivity at any age, though the effect is strongest when started early in perimenopause.

Conclusion

This 306-woman study links a composite insulin resistance score to arterial stiffness specifically in postmenopausal women, while cautioning that the subgroup difference was not statistically confirmed. The broader message is clear: menopause reshapes glucose and lipid metabolism in ways that quietly stress the vasculature. Early metabolic screening and muscle-preserving lifestyle habits remain the most defensible strategy.

Sources:
https://pubmed.ncbi.nlm.nih.gov/42688039/
https://pubmed.ncbi.nlm.nih.gov/42652103/
https://pubmed.ncbi.nlm.nih.gov/42602632/
https://pubmed.ncbi.nlm.nih.gov/42518544/
https://pubmed.ncbi.nlm.nih.gov/42450286/